✦ LIBER ✦

Quality of anticoagulation with unfractionated heparin plus phenprocoumon for the prevention of thromboembolic complications in cardioversion for non-valvular atrial fibrillation. Sub-analysis from the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial

✍ Scribed by Caroline Schmidt-Lucke; W. Dieter Paar; Christoph Stellbrink; Uwe Nixdorff; Thomas Hofmann; Jürgen Meurer; Rolf Grewe; Werner Günther Daniel; Peter Hanrath; Andreas Mügge; Helmut U. Klein; Jan André Schmidt-Lucke

Book ID: 116913388
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 128 KB
Volume: 119
Category: Article
ISSN: 0049-3848
DOI: 10.1016/j.thromres.2005.11.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and efficacy of enoxaparin compar

Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial

✍ C Stellbrink; U Nixdorff; T Hofmann 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Safety and Efficacy of Enoxaparin Compar

Safety and Efficacy of Enoxaparin Compared With Unfractionated Heparin and Oral Anticoagulants for Prevention of Thromboembolic Complications in Cardioversion of Nonvalvular Atrial Fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial

✍ Stellbrink, C. 📂 Article 📅 2004 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 164 KB

Low molecular weight heparin for prevent

Low molecular weight heparin for prevention of thromboembolic complications in cardioversion – rationale and design of the ACE study (Anticoagulation in Cardioversion using Enoxaparin)

✍ Stellbrink, C. ;, ;Hanrath, P. ;Nixdorff, U. ;Hofmann, T. ;Lehmacher, W. ;Kühle 📂 Article 📅 2002 🏛 Springer 🌐 German ⚖ 222 KB

Trial finds that enoxaparin may be the p

Trial finds that enoxaparin may be the preferred drug for initiating anticoagulation in atrial fibrillation: Abstracted from: Stellbrink C, Nixdorff U, Hofmann T, et al. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: The Anticoagulation in Cardioversion using Enoxaparin (ACE) Trial. Circulation 2004; 109: 997-1003.

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 126 KB